The commercial launch of MicrobioTx’s GFT is supported by a grant from DPIIT through the Institute of Life Science, Bhubaneshwar
MicrobioTx, a new-age gut microbiome company, announced the commercial availability of a Gut Function Test (GFT) that profiles gut microbiome with just a few blood drops. With this test, gut microbiome profiling, which was only possible by stool sample, will now be possible with a finger-prick without collecting stool sample. MicrobioTx’s GFT is clinically validated in trials at leading Indian research institutes and has been recently approved by the Indian regulator. The commercial launch of MicrobioTx’s GFT is supported by a grant from DPIIT through the Institute of Life Science, Bhubaneshwar.
Scientific evidence has established that a good gut microbiome could set the foundation for good health, such as better weight management, stronger immunity, and other physiological functions. This breakthrough test solution, developed after three years of intense research, allows users to gain valuable insights into their gut health at a fraction of the cost, making it a smart and affordable choice for everyone.
MicrobioTx’s GFT test is also complemented by consultation, food recommendations, and Personal ProbioTx, a probiotic completely customized based on a user’s gut profile. This allows users to not only know their gut profile but also take personalized actions to address their gut health.
Dr Palok Aich, Professor and Dean R&D, NISER, and one of India’s leading microbiome researchers, said, “By simplifying the process of knowing one’s gut health, the Gut Function Test holds the promise to usher in a new era in wellness. India needs India-specific innovation for healthcare to undergo a paradigm shift. The microbiome is at the cusp of the preventive wave and represents a promising approach.”